"Will a vaccine targeting the Omicron variant be available in the US before April 1, 2022?" is a prediction market on Polymarket where traders buy and sell "Yes" or "No" shares based on whether they believe this event will happen. The current crowd-sourced probability is 0% for "Yes." For example, if "Yes" is priced at 0¢, the market collectively assigns a 0% chance that this event will occur. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

As of today, "Will a vaccine targeting the Omicron variant be available in the US before April 1, 2022?" has generated $29.1K in total trading volume since the market launched on Jan 25, 2022. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.

To trade on "Will a vaccine targeting the Omicron variant be available in the US before April 1, 2022?," simply choose whether you believe the answer is "Yes" or "No." Each side has a current price that reflects the market's implied probability. Enter your amount and click "Trade." If you buy "Yes" shares and the outcome resolves as "Yes," each share pays out $1. If it resolves as "No," your "Yes" shares pay $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current probability for "Will a vaccine targeting the Omicron variant be available in the US before April 1, 2022?" is 0% for "Yes." This means the Polymarket crowd currently believes there is a 0% chance that this event will occur. These odds update in real-time based on actual trades, providing a continuously updated signal of what the market expects to happen.

The resolution rules for "Will a vaccine targeting the Omicron variant be available in the US before April 1, 2022?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.

Yes. You don't need to trade to stay informed. This page serves as a live tracker for "Will a vaccine targeting the Omicron variant be available in the US before April 1, 2022?." The outcome probabilities update in real-time as new trades come in. You can bookmark this page and check the comments section to see what other traders are saying. You can also use the time-range filters on the chart to see how the odds have shifted over time. It's a free, real-time window into what the market expects to happen.

Polymarket odds are set by real traders putting real money behind their beliefs, which tends to surface accurate predictions. With $29.1K traded on “Will a vaccine targeting the Omicron variant be available in the US before April 1, 2022?,” these prices aggregate the collective knowledge and conviction of thousands of participants — often outperforming polls, expert forecasts, and traditional surveys. Prediction markets like Polymarket have a strong track record of accuracy, especially as events approach their resolution date. For example, Polymarket has a one month accuracy score of 94%. For the latest stats on Polymarket’s prediction accuracy, visit the accuracy page on Polymarket.

To place your first trade on "Will a vaccine targeting the Omicron variant be available in the US before April 1, 2022?," sign up for a free Polymarket account and fund it using crypto, a credit or debit card, or a bank transfer. Once your account is funded, return to this page, select the outcome you want to trade, enter your amount, and click "Trade." If you're new to prediction markets, click the "How it works" link at the top of any Polymarket page for a quick step-by-step walkthrough of how trading works.

On Polymarket, the price of "Yes" or "No" represents the market's implied probability. A "Yes" price of 0¢ for "Will a vaccine targeting the Omicron variant be available in the US before April 1, 2022?" means traders collectively believe there is a 0% chance this event will happen. If you buy "Yes" at 0¢ and the event does happen, you receive $1.00 per share — a profit of 100¢ per share. If the event doesn't happen, those shares are worth $0.

The "Will a vaccine targeting the Omicron variant be available in the US before April 1, 2022?" market has been resolved. The final result has been determined and the market is no longer open for trading. You can still review the historical odds, outcome probabilities, and comments on this page to see how predictions evolved over time.

The "Will a vaccine targeting the Omicron variant be available in the US before April 1, 2022?" market was recently created. Be one of the first to share your analysis by posting a comment below, or check back as the market grows to read what other traders think. You can also view the "Activity" tab for a real-time feed of recent trades.

Polymarket is the world's largest prediction market, where you can stay informed and profit from your knowledge of real-world events. Traders buy and sell shares on outcomes for topics ranging from politics and elections to crypto, finance, sports, tech, and culture, including markets like "Will a vaccine targeting the Omicron variant be available in the US before April 1, 2022?." Prices reflect real-time, crowd-sourced probabilities backed by financial conviction, often providing faster and more accurate signals than polls, pundits, or traditional surveys.